Table 1.
Baseline Characteristics (n=36)
| Characteristic | All Patients (n=36) | Responders (n=26) | Non-responders (n=10) | |
|---|---|---|---|---|
| Gender | Women | 19 (52.8%) | 12 (46.2%) | 7 (70.0%) |
| Men | 17 (47.2%) | 14 (53.8%) | 3 (30.0%) | |
| Age [y] | Median | 51.9 | 53.3 | 50.5 |
| Range | 16.2-77.4 | 16.2-77.4 | 31.4-75.3 | |
| Disease Duration [y] | Median | 1.9 | 2.2 | 1.4 |
| Range | 0.1-37.8 | 0.1-37.8 | 0.2-27.6 | |
| Pretreatment | Surgery | 20 (55.6%) | 15 (57.7%) | 5 (50.0%) |
| Chemotherapy | 9 (25.0%) | 6 (23.1%) | 3 (30.0%) | |
| Radiation | 1 (2.8%) | 0 (0%) | 1 (10.0%) | |
| Extent | Single Metastasis | 3 (8.3%) | 3 (11.5%) | 0 (0%) |
| Liver Metastases | 36 (100%) | 26 (100%) | 10 (100%) | |
| Bone Metastases | 5 (13.8%) | 1 (3.8%) | 4 (40.0) | |
| Creatinine [µmol/L] | Median | 68 | 69 | 59 |
| Range | 32-130 | 38-119 | 32-130 | |
| Tumor Uptake | Score 1 | 0 (0%) | 0 (0%) | 0 (0%) |
| Score 2 | 0 (0%) | 0 (0%) | 0 (0%) | |
| Score 3 | 36 (100%) | 26 (100%) | 10 (100%) | |
| Kidney Uptake | Score 0 | 1 (2.8%) | 0 (0%) | 1 (10.0%) |
| Score 1 | 6 (16.7%) | 3 (11.1%) | 3 (30.0%) | |
| Score 2 | 15 (41.7%) | 13 (50.0%) | 2 (20.0%) | |
| Score 3 | 13 (36.1%) | 10 (38.5%) | 3 (30.0%) |